Repligen Corp (RGEN)

144.47 -2.07 (-1.41%) USD  |  NASDAQ  |  Dec 20, 16:00
144.57 +0.10 (+0.07%) After-Hours: 20:00
More

Repligen Max Drawdown (5Y): 64.79% for Nov. 30, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for RGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
West Pharmaceutical Services Inc 55.52%
QuidelOrtho Corp 90.08%
Perspective Therapeutics Inc 91.70%
Xtant Medical Holdings Inc 98.74%
Catheter Precision Inc 100.00%

Max Drawdown (5Y) Related Metrics

Alpha (5Y) -4.151
Beta (5Y) 0.9650
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 48.01%
Historical Sharpe Ratio (5Y) 0.182
Historical Sortino (5Y) 0.3819
Monthly Value at Risk (VaR) 5% (5Y Lookback) 18.40%